Home / Resources / Rare Disease and Orphan Drugs
Resources
VIEW BY TOPIC
Allergy
Autoimmune
Biostatistics
Cell and Gene Therapy
Chemistry, Manufacturing, and Controls (CMC)
Clinical Pharmacology
Clinical Trial Operations
Data Management
Dose Optimization
GxP Compliance
Hematology
Immunology and Inflammation
Infectious Disease and Vaccine
Inspection Readiness
Medical Writing
Modeling and Simulation
Neuroscience
Nonclinical/Preclinical
Oncology
Patient Recruitment and Retention
Pediatric
Pharmacokinetics / Pharmacodynamics
Pharmacovigilance and Drug Safety
Project Management
Protocol Development and Study Design
Publishing and Submissions
Rare Disease and Orphan Drugs
Regulatory Affairs
Study Startup and Site Intelligence
Topic: Rare Disease and Orphan Drugs

Blog
Development Landscape of Therapeutics for Rare Seizure Disorders
View More

Case Study
Overcoming Challenges with Multiple Clinical Outcome Assessments in a Rare Neurodegenerative Clinical Trial
View More

White Paper
Advancing Neurodegenerative Disease Trials with Digital Health Technologies: A Regulatory Aligned Approach
View More

Blog
ICH E11A: Key Features and Implications of the Pediatric Extrapolation Guideline
View More

Webinar
Maximizing Therapeutic Success in Rare Diseases through Basket & Umbrella Trial Designs
View More

Blog
Rare Disease Clinical Trials: Challenges, Strategies, and Solutions for Success
View More

Blog
Sifting Through Rarity: Advanced Patient Screening for Rare Disease Trials
View More

Brochure
Rare Central Nervous System Disease Trials
View More
Industry Featured Article
When it comes to small populations, biotechs need to think big
View More

Webinar
Roadmap To Marketing Authorisation in Europe: Taking All the Right Turns
View More

Blog
FDA Orphan Drug Designation for Rare Diseases
View More

Blog
Rare Disease Research in Central and Eastern Europe
View More